These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2836964)

  • 21. Epitope mapping of an HLA-DR-specific monoclonal antibody produced by using human-mouse transfectant cells.
    Madrigal JA; Ikeda H; Marsh SG; Heyes JM; Kennedy LJ; Trowsdale J; Bodmer JG
    J Immunol; 1989 Dec; 143(12):4084-9. PubMed ID: 2480386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
    Klohe EP; Watts R; Bahl M; Alber C; Yu WY; Anderson R; Silver J; Gregersen PK; Karr RW
    J Immunol; 1988 Sep; 141(6):2158-64. PubMed ID: 2459201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of monoclonal antibodies directed against HLA class II molecules.
    Cabrera T; Ruiz-Cabello F; Lopez MA; de la Higuera B; Sanchez M; Garrido F
    Hybridoma; 1986; 5(3):191-7. PubMed ID: 3770773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epitope analysis with monoclonal antibodies directed against class II molecules subdivides HLA-DR2, DR3 and DR4: correlations with cellularly defined Dw specificities.
    Johnson JP; Nordwig H; Wank R
    Tissue Antigens; 1987 Jan; 29(1):26-33. PubMed ID: 2438806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative and qualitative differences in HLA-DR molecules correlated with antigen-presentation capacity.
    Bontrop R; Ottenhoff T; Van Miltenburg R; Elferink D; De Vries R; Giphart M
    Eur J Immunol; 1986 Feb; 16(2):133-8. PubMed ID: 3485528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicity.
    Aparicio P; Jaraquemada D; López de Castro JA
    J Exp Med; 1987 Feb; 165(2):428-43. PubMed ID: 3102669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The production of a human monoclonal antibody defining a split of HLA-DRw13 (DRw13b).
    Bunce M; Sutton PM; Ting A; Morris PJ
    Tissue Antigens; 1990 Sep; 36(3):100-2. PubMed ID: 2126151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alloimmunization against the platelet specific Zwa antigen associated with HLA-DRw52 and/or DRw6?
    Mueller-Eckhardt G; Mueller-Eckhardt C
    Hum Immunol; 1987 Feb; 18(2):181-3. PubMed ID: 3494004
    [No Abstract]   [Full Text] [Related]  

  • 29. Matching for supertypic DR epitopes does not reduce mixed lymphocyte culture reactivity.
    Nagesser SK; Bosch ML; van Rood JJ; Termijtelen A
    Scand J Immunol; 1987 Oct; 26(4):455-8. PubMed ID: 2446382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibody definition of the DRB3 allele, HLA-Dw25.
    Fuggle SV; Carter C; Morris PJ
    Tissue Antigens; 1989 Sep; 34(3):149-57. PubMed ID: 2480656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cytotoxic human hybridoma monoclonal antibody (TrJ6) defining an epitope expressed by HLA-DQ4 and -DQ5.
    Ge J; Hannestad K
    Hum Immunol; 1994 Feb; 39(2):106-12. PubMed ID: 7513681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of HLA-DR antigens in Japanese patients with sarcoidosis.
    Kunikane H; Abe S; Tsuneta Y; Nakayama T; Tajima Y; Misonou J; Wakisaka A; Aizawa M; Kawakami Y
    Am Rev Respir Dis; 1987 Mar; 135(3):688-91. PubMed ID: 3826893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The single DR beta gene of the DRw8 haplotype is closely related to the DR beta 3III gene encoding DRw52.
    Andersson G; Lindblom B; Andersson L; Gorski J; Mach B; Rask L
    Immunogenetics; 1988; 28(1):1-5. PubMed ID: 3132421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Four cytotoxic human-human hybridoma antibodies that react with HLA-B27.
    Hansen T; Bratlie A; Hannestad K
    Tissue Antigens; 1988 Nov; 32(5):267-77. PubMed ID: 2464858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alloreactive T-lymphocyte clones detecting epitopes uniquely expressed on HLA-D homozygous cells.
    Pawelec G; Wernet P
    Hum Immunol; 1987 Aug; 19(4):279-86. PubMed ID: 2445716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analytical studies of the binding parameters describing the interaction of HLA-DR epitopes with a specific monomorphic monoclonal antibody.
    Labeta MO; Fernandez N; Festenstein H
    J Immunol Methods; 1987 Jul; 101(1):15-21. PubMed ID: 2440953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A human monoclonal hybridoma antibody (TrJ1) specific for HLA-DQ2.
    Ge J; Bartnes K; Hannestad K
    Tissue Antigens; 1993 Feb; 41(2):81-5. PubMed ID: 8386401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Standardization of ICO-1 monoclonal antibodies against monomorphic Ia-like (Dr) antigens].
    Baryshnikov AIu; Blokhina NG; Kadagidze ZG; Tupitsyn NN; Sokolov AV
    Eksp Onkol; 1987; 9(6):45-8. PubMed ID: 2449325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.